Most people will retain access to the antiviral treatments for little to no cost.
WASHINGTON: Most people will retain access to Pfizer’s Paxlovid and Merck’s Lagevrio Covid-19 oral antiviral treatments for little or no cost even after the US government starts handing over their distribution to the commercial market next month, health officials said on Friday.
The US government paid around US$530 per course for Paxlovid, the most commonly prescribed at-home Covid-19 treatment in the country, and made it available at no cost. “The launch of these products, which is what’s going to happen on Nov 1, is not going to bring sudden changes because there’s still an ample supply of federally-owned therapeutics with millions of treatment courses still in the field,” said a US Department of Health and Human Services official.
Providers will be able to order government-supplied Lagevrio until Nov 10 and Paxlovid until Dec 15, the official said, and the government is encouraging them to keep distributing the federal-owned supply they have at no cost until it expires or runs out.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Open payment at Klang Valley KTMB to start from mid-NovKUALA LUMPUR: Commuters of Keretapi Tanah Melayu Berhad (KTMB) Komuter in the Klang Valley will be able to use the open payment system from the middle...
Read more »
1MDB: Nov 6 for decision on prosecution’s bid to amend three charges against NajibA woman who filmed herself arguing with the police after she verbally abused a hospital staff member was sentenced to five weeks and five days’ jail and fined S$600 on Wednesday.
Read more »
1MDB: Nov 6 for decision on prosecution’s bid to amend three chargesKUALA LUMPUR: The High Court here today fixed Nov 6 to deliver its decision on the prosecution’s bid to amend three charges involving power abuse and ...
Read more »
Nov 6 decision on prosecution’s bid to amend Najib’s 1MDB chargesKuala Lumpur: The High Court will decide on Nov 6 whether to allow a bid by prosecutors to amend three of the 25 charges faced by former prime minister Najib Razak in his 1MDB trial.
Read more »
Nov 6 decision on prosecution’s bid to amend Najib’s 1MDB chargesDefence team says it intends to review the evidence to assess the impact of the proposed amendments.
Read more »
6 Nov keputusan permohonan pendakwaan pinda tuduhan 1MDB NajibPeguam bekas perdana menteri memaklumkan mereka memerlukan lebih banyak masa untuk menyediakan penghujahan berhubung permohonan pindaan pihak pendakwaan.
Read more »